STAT October 15, 2024
Hello! Hope you had a restful and reflective Indigenous Peoples’ Day. Today, we talk about how the autoimmune disease space is hotter than ever, see more gene therapy contraction, and the CEO of a generics giant talks about how elections affect industry.
The need-to-know this morning
- Johnson & Johnson reported third-quarter earnings.
Investment in autoimmune disease is soaring
Investment has surged this year in autoimmune disease: More than $1.7 billion has been committed to this space in the first half of the year alone. That surpasses investment in the ultra-hot spaces like cardiometabolic disease and obesity.
The influx, STAT’s Allison DeAngelis writes, is driven largely by breakthroughs in CAR-T therapy, particularly its efficacy in lupus. Cancer companies now...
Today's Sponsors
Today's Sponsor